Alymsys

Generic name: Bevacizumab
Drug class: VEGF/VEGFR inhibitors

Usage of Alymsys

Alymsys is used in adults alone or in combination with other cancer treatments to treat a certain type of brain tumor and certain types of cancers of the kidney, liver, lung, colon, rectum, cervix, ovary, or fallopian tube.

Alymsys is also used to treat cancer of the membrane lining the internal organs in your abdomen. It is usually given as part of a combination of cancer medicines.

Alymsys may also be used for purposes not listed in this medication guide.

Alymsys side effects

Get emergency medical help if you have signs of an allergic reaction: hives, difficult breathing, swelling of your face, lips, tongue, or throat.

Some side effects may occur during the injection. Tell your medical caregiver right away if you feel dizzy, nauseated, light-headed, itchy, sweaty, or have a headache, chest tightness, back pain, trouble breathing, or swelling in your face.

Alymsys can cause a serious but rare neurologic disorder that affects the brain. Symptoms may occur within hours of your first dose or may not appear for up to a year after your treatment started. Call your doctor at once if you have: extreme weakness or tiredness, headache, confusion, vision problems, fainting, or seizures (blackout or convulsions).

Alymsys can cause you to bleed more easily. Call your doctor or seek emergency medical attention if you have:

easy bruising, unusual bleeding, or any bleeding that will not stop;

signs of bleeding in your digestive tract--severe stomach pain, bloody or tarry stools, coughing up blood or vomit that looks like coffee grounds; or

signs of bleeding in the brain--sudden numbness or weakness, slurred speech, severe headache, problems with vision or balance.

Some people taking Alymsys have developed a perforation (a hole or tear) or a fistula (an abnormal passageway) in the stomach, intestines, throat, lungs, gallbladder, kidney, bladder, or vagina. Call your doctor if you have severe stomach pain or if you feel like you are choking when you eat or drink.

Also call your doctor if you have:

slow wound healing;

skin infection or open sores;

missed menstrual periods;

kidney problems--swelling, urinating less, feeling tired or short of breath;

signs of a blood clot--chest pain, sudden cough or shortness of breath, dizziness, coughing up blood, pain, swelling, or warmth in one leg;

heart problems--chest pain or pressure, pain spreading to your jaw or shoulder, nausea, sweating, swelling, rapid weight gain, feeling short of breath; or

low white blood cell counts--fever, mouth sores, skin sores, sore throat, cough.

Your cancer treatments may be delayed or permanently discontinued if you have certain side effects.

Common side effects of Alymsys may include:

increased blood pressure;

headache, back pain;

dry or watery eyes;

dry or flaky skin;

stuffy nose, runny nose, sneezing; or

altered sense of taste.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking Alymsys

You may not be able to use Alymsys if you are being treating with other cancer medicines such as doxorubicin, daunorubicin, or if you have or ever had:

ovarian cancer with symptoms such as severe stomach pain or pelvic pain;

slow healing of a skin wound or surgical incision;

surgery within the past 4 weeks (28 days);

you plan to have surgery within the next 4 weeks (28 days); or

coughing up blood or vomit that looks like coffee grounds.

Tell your doctor if you have ever had:

diabetes;

heart problems such as a heart attack, stroke, blood clot or blood clotting disorder;

high blood pressure;

bleeding problems or a perforation (a hole or tear) in your esophagus, stomach, or intestines; or

kidney disease.

May harm an unborn baby. Do not use if you are pregnant. You may need a pregnancy test to make sure you are not pregnant. Use effective birth control while using Alymsys and for at least 6 months after your last dose. Tell your doctor at once if you become pregnant.

Alymsys may cause a woman's ovaries to stop working correctly. Symptoms of ovarian failure include 3 or more missed menstrual periods in a row. It may be harder for you to get pregnant while you are using Alymsys and after this treatment. Talk to your doctor about your individual risk.

Do not breastfeed while using this medicine and for at least 6 months after your last dose.

Relate drugs

How to use Alymsys

Alymsys is given as an infusion into a vein. A healthcare provider will give you this injection.

Tell your caregivers right away if you feel dizzy, nauseated, light-headed, sweaty, or have a headache, shortness of breath, or chest pain during the injection.

Alymsys is usually given once every 2 or 3 weeks.

Doses are based on weight. Your dose may change if you gain or lose weight.

You may need frequent medical tests and your cancer treatments may be delayed based on the results.

Warnings

Alymsys can make it easier for you to bleed. Seek emergency medical attention if you have any bleeding that will not stop. Bleeding may also happen inside your body.

What other drugs will affect Alymsys

Tell your doctor about all other cancer treatments you are receiving.

Other drugs may affect Alymsys, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all other medicines you use.

Popular FAQ

A biosimilar is a biological product that is similar to a reference biologic (usually the original product) and for which there are no clinically meaningful differences in terms of safety, purity, and potency. As an example, the biosimilar Amjevita (adalimumab-atto) was approved as the first biosimilar to Humira (adalimumab). Continue reading

Eylea, Eylea HD, and Avastin may all be used to treat neovascular (wet) age-related macular degeneration (AMD), as injections into the eye (intravitreal injections). Both Eylea and Eylea HD are FDA-approved for this indication, but use of Avastin is off-label (not an FDA-approved indication - although it has been used for this purpose since 2005). Eylea HD is a longer acting version of Eylea. Continue reading

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.